← Back to Search

Radiation Therapy

SRS/SRT for Brain Tumor

N/A

Waitlist Available

Led By Analiz Rodriguez, MD, PhD

Research Sponsored by University of Arkansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from date of randomization to the date of a documented lr, srn, or lmd, whichever comes first, assessed up to 18 months.

Awards & highlights

Study Summary

This trial will compare the two different approaches to brain surgery in terms of effectiveness in treating brain cancer.

Eligible Conditions

Metastatic Brain Tumors

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from date of randomization to the date of a documented lr, srn, or lmd, whichever comes first, assessed up to 18 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from date of randomization to the date of a documented lr, srn, or lmd, whichever comes first, assessed up to 18 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of randomization to the date of a documented lr, srn, or lmd, whichever comes first, assessed up to 18 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants With Central Nervous System (CNS) Composite Event (CE)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (pre-operative SRS/SRT)Experimental Treatment1 Intervention

Patients undergo SRS or SRT within 15 days of randomization followed by surgery within 15 days of radiation completion. Patients may undergo additional SRS or SRT if disease returns after treatment.

Group II: Arm II (post-operative SRS/SRT)Active Control1 Intervention

Patients undergo surgery within 15 days of randomization followed by standard-of-care SRS or SRT within 30 days of surgery. Patients may undergo additional SRS or SRT if disease returns after treatment.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor

486 Previous Clinical Trials

150,350 Total Patients Enrolled

Analiz Rodriguez, MD, PhDPrincipal InvestigatorUAMS

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has SRS/SRT undergone inspection by the FDA?

"SRS/SRT's safety was given a score of 2 by our team because, while there is some evidence backing its safety, none exists to support efficacy."

Answered by AI

How many people are signing up to participate in this experiment?

"That is correct. The clinical trial, as indicated by its listing on clinicaltrials.gov, is currently looking for participants. This study was originally posted on August 24th, 2020 and has been updated as recently as June 8th, 2022. A total of 104 patients will be admitted across 1 site."

Answered by AI

Are new patients being signed up for this clinical trial right now?

"That is correct. The clinical trial is currently open and was last updated on 6/8/2022. According to the information available, the study hopes to enroll 104 individuals at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases

2020. "Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04422639.